Prognostic Value of Plasma Mitochondrial DNA and Cytochrome C After Cardiac Arrest
1 other identifier
observational
87
1 country
1
Brief Summary
The aim of the study is to determine prognostic value of plasma mitochondrial DNA and cytochrome C after cardiac arrest. The study will be conducted in three parts:
- 1.Determine plasma concentrations of mitochondrial DNA and cytochrome C in healthy population.
- 2.Determine release profile of mitochondrial DNA and cytochrome C to plasma after cardiac arrest.
- 3.Determine plasma prognostic value of mitochondrial DNA and cytochrome C after cardiac arrest and compare it with established prognostic methods.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2019
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 24, 2018
CompletedFirst Posted
Study publicly available on registry
May 29, 2018
CompletedStudy Start
First participant enrolled
January 8, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 23, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2024
CompletedDecember 6, 2023
December 1, 2023
4.6 years
March 24, 2018
December 5, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Correlation of plasma mitochondrial DNA and cytochrome C with survival with good neurological outcome (CPC 1 and 2) at hospital discharge
Relationship between plasma mitochondrial DNA and cytochrome C with neurological damage after cardiac arrest
In hospital mortality, 30days
Interventions
Plasma mitochondrial DNA, plasma Cytochrome C
Eligibility Criteria
Unconscious patients after cardiac arrest treated with therapeutic hypothermia.
You may qualify if:
- unconscious after cardiac arrest
- therapeutic hypothermia
You may not qualify if:
- expected survival less than 24h
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Medical Centre Ljubljanalead
- University of Ljubljanacollaborator
Study Sites (1)
University Medical Centre Ljubljana, Ljubljana, Slovenia
Ljubljana, 1000, Slovenia
Related Publications (5)
Greer DM, Rosenthal ES, Wu O. Neuroprognostication of hypoxic-ischaemic coma in the therapeutic hypothermia era. Nat Rev Neurol. 2014 Apr;10(4):190-203. doi: 10.1038/nrneurol.2014.36. Epub 2014 Mar 11.
PMID: 24614515BACKGROUNDGirotra S, Chan PS, Bradley SM. Post-resuscitation care following out-of-hospital and in-hospital cardiac arrest. Heart. 2015 Dec;101(24):1943-9. doi: 10.1136/heartjnl-2015-307450. Epub 2015 Sep 18.
PMID: 26385451BACKGROUNDArnalich F, Codoceo R, Lopez-Collazo E, Montiel C. Circulating cell-free mitochondrial DNA: a better early prognostic marker in patients with out-of-hospital cardiac arrest. Resuscitation. 2012 Jul;83(7):e162-3. doi: 10.1016/j.resuscitation.2012.03.032. Epub 2012 Apr 7. No abstract available.
PMID: 22490673BACKGROUNDRodrigues Filho EM, Ikuta N, Simon D, Regner AP. Prognostic value of circulating DNA levels in critically ill and trauma patients. Rev Bras Ter Intensiva. 2014 Jul-Sep;26(3):305-12. doi: 10.5935/0103-507x.20140043.
PMID: 25295826BACKGROUNDNakahira K, Hisata S, Choi AM. The Roles of Mitochondrial Damage-Associated Molecular Patterns in Diseases. Antioxid Redox Signal. 2015 Dec 10;23(17):1329-50. doi: 10.1089/ars.2015.6407. Epub 2015 Aug 17.
PMID: 26067258BACKGROUND
Biospecimen
mitochondrial DNA
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Marko Noč, MD
UMC Ljubljana
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
March 24, 2018
First Posted
May 29, 2018
Study Start
January 8, 2019
Primary Completion
August 23, 2023
Study Completion
March 30, 2024
Last Updated
December 6, 2023
Record last verified: 2023-12
Data Sharing
- IPD Sharing
- Will not share